2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors
US11180466B2 · kind B2 · utility
0Cited by
1References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2019 |
| Grant date | Nov 23, 2021 |
| Priority date | — |
| Expiry date | Oct 4, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D213/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a compound of general formula (I): wherein R1, R2, R3, R4, Q, m and n are as defined herein. The compounds are inhibitors of Bcl-3 and are useful for the treatment of cancer, particularly metastatic cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.